FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1583341569> ?p ?o ?g. }

• W1583341569 endingPage "e0131183" @default.
• W1583341569 startingPage "e0131183" @default.
• W1583341569 abstract "Breast cancer is a highly heterogeneous disease that is clinically classified into several subtypes. Among these subtypes, basal-like breast cancer largely overlaps with triple-negative breast cancer (TNBC), and these two groups are generally studied together as a single entity. Differences in the molecular makeup of breast cancers can result in different treatment strategies and prognoses for patients with different breast cancer subtypes. Compared with other subtypes, basal-like and other ER+ breast cancer subtypes exhibit marked differences in etiologic factors, clinical characteristics and therapeutic potential. Anthracycline drugs are typically used as the first-line clinical treatment for basal-like breast cancer subtypes. However, certain patients develop drug resistance following chemotherapy, which can lead to disease relapse and death. Even among patients with basal-like breast cancer, there can be significant molecular differences, and it is difficult to identify specific drug resistance proteins in any given patient using conventional variance testing methods. Therefore, we designed a new method for identifying drug resistance genes. Subgroups, personalized biomarkers, and therapy targets were identified using cluster analysis of differentially expressed genes. We found that basal-like breast cancer could be further divided into at least four distinct subgroups, including two groups at risk for drug resistance and two groups characterized by sensitivity to pharmacotherapy. Based on functional differences among these subgroups, we identified nine biomarkers related to drug resistance: SYK, LCK, GAB2, PAWR, PPARG, MDFI, ZAP70, CIITA and ACTA1. Finally, based on the deviation scores of the examined pathways, 16 pathways were shown to exhibit varying degrees of abnormality in the various subgroups, indicating that patients with different subtypes of basal-like breast cancer can be characterized by differences in the functional status of these pathways. Therefore, these nine differentially expressed genes and their associated functional pathways should provide the basis for novel personalized clinical treatments of basal-like breast cancer." @default.
• W1583341569 created "2016-06-24" @default.
• W1583341569 creator A5013621620 @default.
• W1583341569 creator A5018863416 @default.
• W1583341569 creator A5019290469 @default.
• W1583341569 creator A5021439461 @default.
• W1583341569 creator A5032392988 @default.
• W1583341569 creator A5037201495 @default.
• W1583341569 creator A5062257605 @default.
• W1583341569 creator A5063237870 @default.
• W1583341569 creator A5078276870 @default.
• W1583341569 date "2015-06-30" @default.
• W1583341569 modified "2023-10-16" @default.
• W1583341569 title "Identification of Personalized Chemoresistance Genes in Subtypes of Basal-Like Breast Cancer Based on Functional Differences Using Pathway Analysis" @default.
• W1583341569 cites W1549647993 @default.
• W1583341569 cites W1553190740 @default.
• W1583341569 cites W1560075141 @default.
• W1583341569 cites W1966669762 @default.
• W1583341569 cites W1966861244 @default.
• W1583341569 cites W1985597947 @default.
• W1583341569 cites W1987598102 @default.
• W1583341569 cites W1993069510 @default.
• W1583341569 cites W1996900960 @default.
• W1583341569 cites W2003748401 @default.
• W1583341569 cites W2007997332 @default.
• W1583341569 cites W2008278239 @default.
• W1583341569 cites W2010660231 @default.
• W1583341569 cites W2010846252 @default.
• W1583341569 cites W2023063273 @default.
• W1583341569 cites W2024061577 @default.
• W1583341569 cites W2050936961 @default.
• W1583341569 cites W2072156953 @default.
• W1583341569 cites W2104074461 @default.
• W1583341569 cites W2113661022 @default.
• W1583341569 cites W2134539328 @default.
• W1583341569 cites W2134912906 @default.
• W1583341569 cites W2139795964 @default.
• W1583341569 cites W2141589190 @default.
• W1583341569 cites W2146973482 @default.
• W1583341569 cites W2149440086 @default.
• W1583341569 cites W2150926065 @default.
• W1583341569 cites W2155781648 @default.
• W1583341569 cites W2157795344 @default.
• W1583341569 cites W2166322560 @default.
• W1583341569 cites W2183585337 @default.
• W1583341569 cites W4294107304 @default.
• W1583341569 doi "https://doi.org/10.1371/journal.pone.0131183" @default.
• W1583341569 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4488356" @default.
• W1583341569 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26126114" @default.
• W1583341569 hasPublicationYear "2015" @default.
• W1583341569 type Work @default.
• W1583341569 sameAs 1583341569 @default.
• W1583341569 citedByCount "18" @default.
• W1583341569 countsByYear W15833415692016 @default.
• W1583341569 countsByYear W15833415692017 @default.
• W1583341569 countsByYear W15833415692018 @default.
• W1583341569 countsByYear W15833415692019 @default.
• W1583341569 countsByYear W15833415692020 @default.
• W1583341569 countsByYear W15833415692021 @default.
• W1583341569 countsByYear W15833415692022 @default.
• W1583341569 countsByYear W15833415692023 @default.
• W1583341569 crossrefType "journal-article" @default.
• W1583341569 hasAuthorship W1583341569A5013621620 @default.
• W1583341569 hasAuthorship W1583341569A5018863416 @default.
• W1583341569 hasAuthorship W1583341569A5019290469 @default.
• W1583341569 hasAuthorship W1583341569A5021439461 @default.
• W1583341569 hasAuthorship W1583341569A5032392988 @default.
• W1583341569 hasAuthorship W1583341569A5037201495 @default.
• W1583341569 hasAuthorship W1583341569A5062257605 @default.
• W1583341569 hasAuthorship W1583341569A5063237870 @default.
• W1583341569 hasAuthorship W1583341569A5078276870 @default.
• W1583341569 hasBestOaLocation W15833415691 @default.
• W1583341569 hasConcept C114851261 @default.
• W1583341569 hasConcept C121608353 @default.
• W1583341569 hasConcept C126322002 @default.
• W1583341569 hasConcept C143998085 @default.
• W1583341569 hasConcept C2778024521 @default.
• W1583341569 hasConcept C2779134260 @default.
• W1583341569 hasConcept C2779306644 @default.
• W1583341569 hasConcept C530470458 @default.
• W1583341569 hasConcept C54355233 @default.
• W1583341569 hasConcept C60644358 @default.
• W1583341569 hasConcept C71924100 @default.
• W1583341569 hasConcept C86803240 @default.
• W1583341569 hasConceptScore W1583341569C114851261 @default.
• W1583341569 hasConceptScore W1583341569C121608353 @default.
• W1583341569 hasConceptScore W1583341569C126322002 @default.
• W1583341569 hasConceptScore W1583341569C143998085 @default.
• W1583341569 hasConceptScore W1583341569C2778024521 @default.
• W1583341569 hasConceptScore W1583341569C2779134260 @default.
• W1583341569 hasConceptScore W1583341569C2779306644 @default.
• W1583341569 hasConceptScore W1583341569C530470458 @default.
• W1583341569 hasConceptScore W1583341569C54355233 @default.
• W1583341569 hasConceptScore W1583341569C60644358 @default.
• W1583341569 hasConceptScore W1583341569C71924100 @default.
• W1583341569 hasConceptScore W1583341569C86803240 @default.
• W1583341569 hasIssue "6" @default.
• W1583341569 hasLocation W15833415691 @default.

• next